Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 231

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Life expectancy associated with different ages at diagnosis of type 2 diabetes in high-income countries: 23 million person-years of observation

Open access
Kaptoge, S, Seshasai, SRK, Sun, L, Walker, M, Bolton, T, Spackman, S, Ataklte, F, Willeit, P, Bell, S, Burgess, S, Pennells, L, Altay, S, Assmann, G, Ben-Shlomo, Y, Best, LG, Björkelund, C, Blazer, DG, Brenner, H, Brunner, EJ, Dagenais, GR, Cooper, JA, Cooper, C, Crespo, CJ, Cushman, M, D'Agostino, RB, Daimon, M, Daniels, LB, Danker, R, Davidson, KW, de Jongh, RT, Donfrancesco, C, Ducimetiere, P, Elders, PJM, Engström, G, Ford, I, Gallacher, I, Bakker, SJL, Goldbourt, U, de La Cámara, G, Grimsgaard, S, Gudnason, V, Hansson, PO, Imano, H, Jukema, JW, Kabrhel, C, Kauhanen, J, Kavousi, M, Kiechl, S, Knuiman, MW, Kromhout, D, Krumholz, HM, Kuller, LH, Laatikainen, T, Lowler, DA, Meyer, HE, Mukamal, K, Nietert, PJ, Ninomiya, T, Nitsch, D, Nordestgaard, BG, Palmieri, L, Price, JF, Ridker, PM, Sun, Q, Rosengren, A, Roussel, R, Sakurai, M, Salomaa, V, Schöttker, B, Shaw, JE, Strandberg, TE, Sundström, J, Tolonen, H, Tverdal, A, Verschuren, WMM, Völzke, H, Wagenknecht, L, Wallace, RB, Wannamethee, SG, Wareham, NJ, Wassertheil-Smoller, S, Yamagishi, K, Yeap, BB, Harrison, S, Inouye, M, Griffin, S, Butterworth, AS, Wood, AM, Thompson, SG, Sattar, N, Danesh, J, Di Angelantonio, E, Tipping, RW, Russell, S, Johansen, M, Bancks, MP, Mongraw-Chaffin, M, Magliano, D, Barr, ELM, Zimmet, PZ, Knuiman, MW, Whincup, PH, Willeit, J, Willeit, P, Leitner, C, Lawlor, DA, Ben-Shlomo, Y, Elwood, P, Sutherland, SE, Hunt, KJ, Cushman, M, Selmer, RM, Haheim, LL, Ariansen, I, Tybjaer-Hansen, A, Frikkle-Schmidt, R, Langsted, A, Donfrancesco, C, Lo Noce, C, Balkau, B, Bonnet, F, Fumeron, F, Pablos, DL, Ferro, CR, Morales, TG, Mclachlan, S, Guralnik, J, Khaw, KT, Brenner, H, Holleczek, B, Stocker, H, Nissinen, A, Palmieri, L, Vartiainen, E, Jousilahti, P, Harald, K, Massaro, JM, Pencina, M, Lyass, A, Susa, S, Oizumi, T, Kayama, T, Chetrit, A, Roth, J, Orenstein, L, Welin, L, Svärdsudd, K, Lissner, L, Hange, D, Mehlig, K, Salomaa, V, Tilvis, RS, Dennison, E, Cooper, C, Westbury, L, Norman, PE, Almeida, OP, Hankey, GJ, Hata, J, Shibata, M, Furuta, Y, Bom, MT, Rutters, F, Muilwijk, M, Kraft, P, Lindstrom, S, Turman, C, Kiyama, M, Kitamura, A, Yamagishi, K, Gerber, Y, Laatikainen, T, Salonen, JT, van Schoor, LN, van Zutphen, EM, Verschuren, WMM, Engström, G, Melander, O, Psaty, BM, Blaha, M, de Boer, IH, Kronmal, RA, Sattar, N, Rosengren, A, Nitsch, D, Grandits, G, Tverdal, A, Shin, H-C, Albertorio, JR, Gillum, RF, Hu, FB, Cooper, JA, Humphries, S, Hill- Briggs, F, Vrany, E, Butler, M, Schwartz, JE, Kiyama, M, Kitamura, A, Iso, H, Amouyel, P, Arveiler, D, Ferrieres, J, Gansevoort, RT, de Boer, R, Kieneker, L, Crespo, CJ, Assmann, G, Trompet, S, Kearney, P, Cantin, B, Després, JP, Lamarche, B, Laughlin, G, McEvoy, L, Aspelund, T, Thorsson, B, Sigurdsson, G, Tilly, M, Ikram, MA, Dorr, M, Schipf, S, Völzke, H, Fretts, AM, Umans, JG, Ali, T, Shara, N, Davey-Smith, G, Can, G, Yüksel, H, Özkan, U, Nakagawa, H, Morikawa, Y, Ishizaki, M, Njølstad, I, Wilsgaard, T, Mathiesen, E, Sundström, J, Buring, J, Cook, N, Arndt, V, Rothenbacher, D, Manson, J, Tinker, L, Shipley, M, Tabak, AG, Kivimaki, M, Packard, C, Robertson, M, Feskens, E, Geleijnse, M, Kromhout, D · 2023 · The Lancet Diabetes & Endocrinology

Abstract

BACKGROUND: The prevalence of type 2 diabetes is increasing rapidly, particularly among younger age groups. Estimates suggest that people with diabetes die, on average, 6 years earlier than people without diabetes. We aimed to provide reliable estimates of the associations between age at diagnosis of diabetes and all-cause mortality, cause-specific mortality, and reductions in life expectancy. METHODS: For this observational study, we conducted a combined analysis of individual-participant data from 19 high-income countries using two large-scale data sources: the Emerging Risk Factors Collaboration (96 cohorts, median baseline years 1961-2007, median latest follow-up years 1980-2013) and the UK Biobank (median baseline year 2006, median latest follow-up year 2020). We calculated age-adjusted and sex-adjusted hazard ratios (HRs) for all-cause mortality according to age at diagnosis of diabetes using data from 1 515 718 participants, in whom deaths were recorded during 23·1 million person-years of follow-up. We estimated cumulative survival by applying age-specific HRs to age-specific death rates from 2015 for the USA and the EU. FINDINGS: For participants with diabetes, we observed a linear dose-response association between earlier age at diagnosis and higher risk of all-cause mortality compared with participants without diabetes. HRs were 2·69 (95% CI 2·43-2·97) when diagnosed at 30-39 years, 2·26 (2·08-2·45) at 40-49 years, 1·84 (1·72-1·97) at 50-59 years, 1·57 (1·47-1·67) at 60-69 years, and 1·39 (1·29-1·51) at 70 years and older. HRs per decade of earlier diagnosis were similar for men and women. Using death rates from the USA, a 50-year-old individual with diabetes died on average 14 years earlier when diagnosed aged 30 years, 10 years earlier when diagnosed aged 40 years, or 6 years earlier when diagnosed aged 50 years than an individual without diabetes. Using EU death rates, the corresponding estimates were 13, 9, or 5 years earlier. INTERPRETATION: Every decade of earlier diagnosis of diabetes was associated with about 3-4 years of lower life expectancy, highlighting the need to develop and implement interventions that prevent or delay the onset of diabetes and to intensify the treatment of risk factors among young adults diagnosed with diabetes. FUNDING: British Heart Foundation, Medical Research Council, National Institute for Health and Care Research, and Health Data Research UK.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s2213-8587(23)00223-1

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 13 references

Research works printed but not linked: 37

  1. Zhou, 2016, Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4·4 million participants, Lancet, 387, 1513, 10.1016/S0140-6736(16)00618-8 · DOI · Paper page
  2. Geiss, 2014, Prevalence and incidence trends for diagnosed diabetes among adults aged 20 to 79 years, United States, 1980–2012, JAMA, 312, 1218, 10.1001/jama.2014.11494 · DOI · Paper page
  3. Gregg, 2014, Trends in lifetime risk and years of life lost due to diabetes in the USA, 1985–2011: a modelling study, Lancet Diabetes Endocrinol, 2, 867, 10.1016/S2213-8587(14)70161-5 · DOI · Paper page
  4. Tomic, 2022, Lifetime risk, life expectancy, and years of life lost to type 2 diabetes in 23 high-income jurisdictions: a multinational, population-based study, Lancet Diabetes Endocrinol, 10, 795, 10.1016/S2213-8587(22)00252-2 · DOI
  5. Pavkov, 2006, Effect of youth-onset type 2 diabetes mellitus on incidence of end-stage renal disease and mortality in young and middle-aged Pima Indians, JAMA, 296, 421, 10.1001/jama.296.4.421 · DOI · Paper page
  6. Barnett, 2010, A 12-year follow-up study of all-cause and cardiovascular mortality among 10,532 people newly diagnosed with Type 2 diabetes in Tayside, Scotland, Diabet Med, 27, 1124, 10.1111/j.1464-5491.2010.03075.x · DOI
  7. Gulliford, 2009, Is relative mortality of type 2 diabetes mellitus decreasing?, Am J Epidemiol, 169, 455, 10.1093/aje/kwn342 · DOI
  8. Di Angelantonio, 2015, Association of cardiometabolic multimorbidity with mortality, JAMA, 314, 52, 10.1001/jama.2015.7008 · DOI · Paper page
  9. Al-Saeed, 2016, An inverse relationship between age of type 2 diabetes onset and complication risk and mortality: the impact of youth-onset type 2 diabetes, Diabetes Care, 39, 823, 10.2337/dc15-0991 · DOI · Paper page
  10. Brun, 2000, Diabetes duration and cause-specific mortality in the Verona Diabetes Study, Diabetes Care, 23, 1119, 10.2337/diacare.23.8.1119 · DOI
  11. Silbernagel, 2012, Duration of type 2 diabetes strongly predicts all-cause and cardiovascular mortality in people referred for coronary angiography, Atherosclerosis, 221, 551, 10.1016/j.atherosclerosis.2012.01.011 · DOI
  12. Herrington, 2018, Effect of diabetes duration and glycaemic control on 14-year cause-specific mortality in Mexican adults: a blood-based prospective cohort study, Lancet Diabetes Endocrinol, 6, 455, 10.1016/S2213-8587(18)30050-0 · DOI
  13. Wannamethee, 2011, Impact of diabetes on cardiovascular disease risk and all-cause mortality in older men: influence of age at onset, diabetes duration, and established and novel risk factors, Arch Intern Med, 171, 404, 10.1001/archinternmed.2011.2 · DOI · Paper page
  14. Huo, 2018, Impact of age at diagnosis and duration of type 2 diabetes on mortality in Australia 1997–2011, Diabetologia, 61, 1055, 10.1007/s00125-018-4544-z · DOI · Paper page
  15. Færch, 2014, Improved survival among patients with complicated type 2 diabetes in Denmark: a prospective study (2002–2010), J Clin Endocrinol Metab, 99, E642, 10.1210/jc.2013-3210 · DOI
  16. Knuiman, 1992, An analysis of excess mortality rates for persons with non-insulin-dependent diabetes mellitus in Western Australia using the Cox proportional hazards regression model, Am J Epidemiol, 135, 638, 10.1093/oxfordjournals.aje.a116343 · DOI
  17. Li, 2012, Mortality trends in patients with diabetes in Taiwan: a nationwide survey in 2000–2009, J Formos Med Assoc, 111, 645, 10.1016/j.jfma.2012.09.013 · DOI
  18. Holden, 2013, The incidence of type 2 diabetes in the United Kingdom from 1991 to 2010, Diabetes Obes Metab, 15, 844, 10.1111/dom.12123 · DOI · Paper page
  19. Nwaneri, 2012, Falling mortality rates in type 2 diabetes mellitus in the Wirral Peninsula: a longitudinal and retrospective cohort population-based study, Postgrad Med J, 88, 679, 10.1136/postgradmedj-2012-130877 · DOI
  20. Huo, 2016, Risk of non-fatal cardiovascular diseases in early-onset versus late-onset type 2 diabetes in China: a cross-sectional study, Lancet Diabetes Endocrinol, 4, 115, 10.1016/S2213-8587(15)00508-2 · DOI · Paper page
  21. Alva, 2018, State-level diabetes-attributable mortality and years of life lost in the United States, Ann Epidemiol, 28, 790, 10.1016/j.annepidem.2018.08.015 · DOI
  22. Tönnies, 2021, Diabetes free life expectancy and years of life lost associated with type 2 diabetes: projected trends in Germany between 2015 and 2040, Popul Health Metr, 19, 38, 10.1186/s12963-021-00266-z · DOI
  23. Koyama, 2022, Trends in lifetime risk and years of potential life lost from diabetes in the United States, 1997–2018, PLoS One, 17, 10.1371/journal.pone.0268805 · DOI
  24. Leung, 2015, Life years lost and lifetime health care expenditures associated with diabetes in the U.S., National Health Interview Survey, 1997–2000, Diabetes Care, 38, 460, 10.2337/dc14-1453 · DOI
  25. 2007, The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases, Eur J Epidemiol, 22, 839, 10.1007/s10654-007-9165-7 · DOI · Paper page
  26. Pintilie, 2007, Analysing and interpreting competing risk data, Stat Med, 26, 1360, 10.1002/sim.2655 · DOI · Paper page
  27. Freidlin, 2005, Testing treatment effects in the presence of competing risks, Stat Med, 24, 1703, 10.1002/sim.2054 · DOI
  28. Tai, 2008, First-event or marginal estimation of cause-specific hazards for analysing correlated multivariate failure-time data?, Stat Med, 27, 922, 10.1002/sim.2944 · DOI
  29. Thompson, 2010, Statistical methods for the time-to-event analysis of individual participant data from multiple epidemiological studies, Int J Epidemiol, 39, 1345, 10.1093/ije/dyq063 · DOI
  30. Higgins, 2002, Quantifying heterogeneity in a meta-analysis, Stat Med, 21, 1539, 10.1002/sim.1186 · DOI · Paper page
  31. Lewington, 2002, Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies, Lancet, 360, 1903, 10.1016/S0140-6736(02)11911-8 · DOI · Paper page
  32. Steinarsson, 2018, Short-term progression of cardiometabolic risk factors in relation to age at type 2 diabetes diagnosis: a longitudinal observational study of 100,606 individuals from the Swedish National Diabetes Register, Diabetologia, 61, 599, 10.1007/s00125-017-4532-8 · DOI
  33. Zoungas, 2014, Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes, Diabetologia, 57, 2465, 10.1007/s00125-014-3369-7 · DOI · Paper page
  34. Porta, 2014, Estimating the delay between onset and diagnosis of type 2 diabetes from the time course of retinopathy prevalence, Diabetes Care, 37, 1668, 10.2337/dc13-2101 · DOI
  35. Thomas, 2018, Frequency and phenotype of type 1 diabetes in the first six decades of life: a cross-sectional, genetically stratified survival analysis from UK Biobank, Lancet Diabetes Endocrinol, 6, 122, 10.1016/S2213-8587(17)30362-5 · DOI · Paper page
  36. Mansournia, 2022, A practical guide to handling competing events in etiologic time-to-event studies, Glob Epidemiol, 4
  37. Hernán, 2010, The hazards of hazard ratios, Epidemiology, 21, 13, 10.1097/EDE.0b013e3181c1ea43 · DOI · Paper page

Cited by

See all 231

Metadata

Authors
Kaptoge, S., Seshasai, S., Sun, L., Walker, M., Bolton, T., Spackman, S., Ataklte, F., Willeit, P., Bell, S., Burgess, S., Pennells, L., Altay, S., Assmann, G., Ben-Shlomo, Y., Best, L., Björkelund, C., Blazer, D., Brenner, H., Brunner, E., Dagenais, G., Cooper, J., Cooper, C., Crespo, C., Cushman, M., D'Agostino, R., Daimon, M., Daniels, L., Danker, R., Davidson, K., de Jongh, R., Donfrancesco, C., Ducimetiere, P., Elders, P., Engström, G., Ford, I., Gallacher, I., Bakker, S., Goldbourt, U., de La Cámara, G., Grimsgaard, S., Gudnason, V, Hansson, P., Imano, H., Jukema, J., Kabrhel, C., Kauhanen, J., Kavousi, M., Kiechl, S., Knuiman, M., Kromhout, D., Krumholz, H., Kuller, L., Laatikainen, T., Lowler, D., Meyer, H., Mukamal, K., Nietert, P., Ninomiya, T., Nitsch, D., Nordestgaard, B., Palmieri, L., Price, J., Ridker, P., Sun, Q., Rosengren, A., Roussel, R., Sakurai, M., Salomaa, V, Schöttker, B., Shaw, J., Strandberg, T., Sundström, J., Tolonen, H., Tverdal, A., Verschuren, W., Völzke, H., Wagenknecht, L., Wallace, R., Wannamethee, S., Wareham, N., Wassertheil-Smoller, S., Yamagishi, K., Yeap, B., Harrison, S., Inouye, M., Griffin, S., Butterworth, A., Wood, A., Thompson, S., Sattar, N., Danesh, J., Di Angelantonio, E., Tipping, R., Russell, S., Johansen, M., Bancks, M., Mongraw-Chaffin, M., Magliano, D., Barr, E., Zimmet, P., Knuiman, M., Whincup, P., Willeit, J., Willeit, P., Leitner, C., Lawlor, D., Ben-Shlomo, Y., Elwood, P., Sutherland, S., Hunt, K., Cushman, M., Selmer, R., Haheim, L., Ariansen, I., Tybjaer-Hansen, A., Frikkle-Schmidt, R., Langsted, A., Donfrancesco, C., Lo Noce, C., Balkau, B., Bonnet, F., Fumeron, F., Pablos, D., Ferro, C., Morales, T., Mclachlan, S., Guralnik, J., Khaw, K., Brenner, H., Holleczek, B., Stocker, H., Nissinen, A., Palmieri, L., Vartiainen, E., Jousilahti, P., Harald, K., Massaro, J., Pencina, M., Lyass, A., Susa, S., Oizumi, T., Kayama, T., Chetrit, A., Roth, J., Orenstein, L., Welin, L., Svärdsudd, K., Lissner, L., Hange, D., Mehlig, K., Salomaa, V, Tilvis, R., Dennison, E., Cooper, C., Westbury, L., Norman, P., Almeida, O., Hankey, G., Hata, J., Shibata, M., Furuta, Y., Bom, M., Rutters, F., Muilwijk, M., Kraft, P., Lindstrom, S., Turman, C., Kiyama, M., Kitamura, A., Yamagishi, K., Gerber, Y., Laatikainen, T., Salonen, J., van Schoor, L., van Zutphen, E., Verschuren, W., Engström, G., Melander, O., Psaty, B., Blaha, M., de Boer, I., Kronmal, R., Sattar, N., Rosengren, A., Nitsch, D., Grandits, G., Tverdal, A., Shin, H.-C., Albertorio, Jr., Gillum, R., Hu, F., Cooper, J., Humphries, S., Hill- Briggs, F., Vrany, E., Butler, M., Schwartz, J., Kiyama, M., Kitamura, A., Iso, H., Amouyel, P., Arveiler, D., Ferrieres, J., Gansevoort, R., de Boer, R., Kieneker, L., Crespo, C., Assmann, G., Trompet, S., Kearney, P., Cantin, B., Després, J., Lamarche, B., Laughlin, G., McEvoy, L., Aspelund, T., Thorsson, B., Sigurdsson, G., Tilly, M., Ikram, M., Dorr, M., Schipf, S., Völzke, H., Fretts, A., Umans, J., Ali, T., Shara, N., Davey-Smith, G., Can, G., Yüksel, H., Özkan, U., Nakagawa, H., Morikawa, Y., Ishizaki, M., Njølstad, I., Wilsgaard, T., Mathiesen, E., Sundström, J., Buring, J., Cook, N., Arndt, V, Rothenbacher, D., Manson, J., Tinker, L., Shipley, M., Tabak, A., Kivimaki, M., Packard, C., Robertson, M., Feskens, E., Geleijnse, M., & Kromhout, D.
Venue
The Lancet Diabetes & Endocrinology
Publisher
Elsevier BV
Published
2023-10
Volume
11
Issue
10
Pages
731-742
ISSN
2213-8587 (ISSN-L)
OpenAlex
W4386594957
Cited by
231
References
13
FWCI
38.39
Type
journal article
Language
en
Open access
hybrid
Licence
Funders
  • NIHR Cambridge Biomedical Research Centre (BCDSA\\100005, NIHR203312, 116074, BRC-1215-20014)
  • Economic and Social Research Council (ES/T013192/1)
  • British Heart Foundation (RG/18/13/33946, CH/12/2/29428)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Life expectancy associated with different ages at diagnosis of type 2 diabetes in high-income countries: 23 million person-years of observation. https://app.cochat.ai/papers/10.1016/s2213-8587(23)00223-1
The paper
Kaptoge, S., Seshasai, S., Sun, L., Walker, M., Bolton, T., Spackman, S., Ataklte, F., Willeit, P., Bell, S., Burgess, S., Pennells, L., Altay, S., Assmann, G., Ben-Shlomo, Y., Best, L., Björkelund, C., Blazer, D., Brenner, H., Brunner, E., . . . Kromhout, D. (2023). Life expectancy associated with different ages at diagnosis of type 2 diabetes in high-income countries: 23 million person-years of observation. The Lancet Diabetes & Endocrinology. https://doi.org/10.1016/s2213-8587(23)00223-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.